Predictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1b. / Goodin, Douglas; Reder, Anthony; Traboulsee, Anthony; Li, David; Langdon, Dawn; Cutter, Gary; Cook, Stuart ; O'Donnell, Timothy; Kremenchutzky, Marcelo; Oger, Joel; Koelbach, Ralf; Pohl, Christoph; Wicklein, Eva-Maria.
In: Multiple Sclerosis Journal, 15.05.2018, p. 1-11.Research output: Contribution to journal › Article
E-pub ahead of print
Documents
- Goodin NEDA MSJ author accepted manuscript
Accepted author manuscript, 490 KB, Word-document
| Original language | English |
|---|---|
| Pages (from-to) | 1-11 |
| Number of pages | 11 |
| Journal | Multiple Sclerosis Journal |
| Early online date | 15 May 2018 |
| DOIs | |
| State | E-pub ahead of print - 15 May 2018 |
This open access research output is licenced under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.
ID: 29849677